Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $9.14 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.85.
Market Cap
9.14T
Revenue
4.67T
Profits
191.06B
PE Ratio
47.85
Profit Margin
4.10%
Dividend Yield
0.39%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | 2.70% | 2,305,018 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 622.84B | 1.44% | 5,405,016 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 479.52B | 1.75% | 6,079,078 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 352.29B | 0.60% | 6,353,502 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 337.48B | -0.09% | 5,633,144 | 450.53B |
| 6 | NVS | Novartis AG | 273.66B | 1.77% | 1,852,254 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 249.50B | 0.95% | 2,458,720 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 244.79B | 0.83% | 1,825,429 | 46.34B |
| 9 | AMGN | Amgen Inc. | 223.32B | 2.60% | 2,237,193 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 182.09B | 1.82% | 5,097,194 | 30.46B |
| 11 | ABT | Abbott Laboratories | 170.84B | 0.58% | 9,392,438 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 168.08B | 1.95% | 13,665,078 | 50.34B |
| 13 | PFE | Pfizer Inc. | 159.59B | 1.82% | 31,230,399 | 63.70B |
| 14 | DHR | Danaher Corporation | 153.60B | 1.34% | 3,974,177 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 146.44B | 2.41% | 1,896,441 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 128.16B | 0.66% | 806,841 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.95B | 0.18% | 11,091,915 | 49.19B |
| 18 | CVS | CVS Health Corporation | 112.49B | 1.76% | 8,468,977 | 412.65B |
| 19 | MDT | Medtronic plc | 109.38B | -1.81% | 55,892,020 | 37.54B |
| 20 | MCK | McKesson Corporation | 106.14B | -1.23% | 794,460 | 410.98B |
| 21 | SYK | Stryker Corporation | 105.64B | -1.01% | 1,918,974 | 25.84B |
| 22 | SNY | Sanofi | 96.29B | 1.62% | 2,081,839 | 55.89B |
| 23 | HCA | HCA Healthcare, Inc. | 95.08B | 1.61% | 999,017 | 78.01B |
| 24 | GSK | GSK plc | 94.75B | 0.90% | 5,852,629 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 87.68B | 1.05% | 904,789 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 78.44B | 4.81% | 14,640,182 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 74.10B | 0.46% | 626,433 | 15.53B |
| 28 | CI | The Cigna Group | 73.59B | 1.51% | 1,632,960 | 282.38B |
| 29 | COR | Cencora, Inc. | 60.54B | 0.28% | 1,060,757 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 60.26B | -1.45% | 15,892,351 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.72B | 1.49% | 2,556,459 | 28.42B |
| 32 | ARGX | argenx SE | 58.70B | -0.22% | 258,330 | 5.32B |
| 33 | NTRA | Natera, Inc. | 57.02B | -1.27% | 2,816,863 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 53.76B | -0.55% | 1,096,895 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 49.44B | -0.81% | 3,508,089 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.07B | -0.08% | 1,922,325 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 47.67B | -0.14% | 2,555,408 | 7.37B |
| 38 | HUM | Humana Inc. | 47.61B | -1.92% | 1,827,931 | 145.68B |
| 39 | MDLN | Medline Inc. | 46.61B | -0.28% | 4,472,219 | 29.94B |
| 40 | VEEV | Veeva Systems Inc. | 45.74B | -0.35% | 1,120,109 | 3.46B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 45.66B | 0.13% | 3,455,523 | 17.32B |
| 42 | RVMD | Revolution Medicines, Inc. | 43.05B | 0.50% | 1,185,197 | - |
| 43 | WAT | Waters Corporation | 42.84B | -0.10% | 770,896 | 4.64B |
| 44 | IQV | IQVIA Holdings Inc. | 42.48B | -0.72% | 1,406,064 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 41.39B | 0.34% | 148,635 | 6.13B |
| 46 | ILMN | Illumina, Inc. | 40.43B | -2.11% | 2,949,517 | 4.49B |
| 47 | IDXX | IDEXX Laboratories, Inc. | 39.92B | -1.70% | 716,450 | 4.55B |
| 48 | HLN | Haleon plc | 39.83B | 1.69% | 18,243,583 | 14.80B |
| 49 | BIIB | Biogen Inc. | 32.82B | -0.33% | 1,298,200 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 32.64B | 0.57% | 3,671,204 | 2.54B |
| 51 | CNC | Centene Corporation | 32.10B | 0.59% | 5,217,332 | 180.30B |
| 52 | DXCM | DexCom, Inc. | 31.81B | 1.09% | 2,863,835 | 4.97B |
| 53 | RMD | ResMed Inc. | 31.78B | 2.40% | 1,128,411 | 5.65B |
| 54 | MTD | Mettler-Toledo International Inc. | 30.73B | 0.03% | 227,200 | 4.13B |
| 55 | ALC | Alcon Inc. | 30.56B | -0.30% | 1,544,268 | 10.86B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.03B | 0.21% | 1,064,112 | 4.80B |
| 57 | ZTS | Zoetis Inc. | 29.57B | 0.31% | 4,128,178 | 9.53B |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.21B | -0.15% | 4,065,667 | 21.27B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.79B | -1.65% | 438,035 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 25.30B | 0.08% | 546,619 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.10B | -2.20% | 5,740,295 | 7.53M |
| 62 | DGX | Quest Diagnostics Incorporated | 25.06B | -0.58% | 927,428 | 11.56B |
| 63 | BNTX | BioNTech SE | 23.93B | -0.50% | 828,076 | 3.03B |
| 64 | PHG | Koninklijke Philips N.V. | 23.55B | -0.25% | 1,443,388 | 20.18B |
| 65 | UTHR | United Therapeutics Corporation | 23.38B | 0.62% | 1,005,292 | 3.15B |
| 66 | INCY | Incyte Corporation | 22.99B | 0.63% | 1,274,765 | 5.82B |
| 67 | GH | Guardant Health, Inc. | 22.59B | -1.38% | 2,200,617 | 1.18B |
| 68 | GMAB | Genmab A/S | 22.24B | -3.04% | 4,253,685 | 4.13B |
| 69 | INSM | Insmed Incorporated | 22.22B | -3.32% | 3,164,310 | 1.14B |
| 70 | THC | Tenet Healthcare Corporation | 20.92B | 0.53% | 475,694 | 21.81B |
| 71 | STE | STERIS plc | 20.44B | 0.49% | 669,841 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.09B | -0.29% | 7,543,947 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 17.14B | 0.20% | 2,233,643 | 2.91B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 16.88B | -1.33% | 1,991,445 | 8.51B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.87B | 0.22% | 207,572 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.01B | -0.09% | 578,908 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.00B | 1.04% | 820,548 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.62B | -1.33% | 981,192 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.58B | -1.40% | 1,143,738 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.48B | 0.19% | 2,374,786 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 14.36B | 3.70% | 8,175,297 | - |
| 82 | CRL | Charles River Laboratories International, Inc. | 14.34B | -1.53% | 1,242,236 | 4.00B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.29B | 0.08% | 1,964,666 | 14.37B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.00B | -0.69% | 2,064,385 | 713.07M |
| 85 | CORT | Corcept Therapeutics Incorporated | 12.93B | 0.03% | 634,876 | 830.81M |
| 86 | TEM | Tempus AI, Inc. | 12.69B | -2.26% | 9,013,653 | 1.43B |
| 87 | ICLR | ICON Public Limited Company | 12.66B | 1.48% | 776,243 | 8.29B |
| 88 | HALO | Halozyme Therapeutics, Inc. | 12.57B | 0.98% | 2,179,313 | 1.66B |
| 89 | PEN | Penumbra, Inc. | 12.46B | -0.22% | 366,187 | 1.50B |
| 90 | BAX | Baxter International Inc. | 12.39B | -1.60% | 4,770,357 | 11.47B |
| 91 | EHC | Encompass Health Corporation | 12.08B | -1.77% | 875,468 | 6.21B |
| 92 | TECH | Bio-Techne Corporation | 11.37B | 0.14% | 3,153,715 | 1.22B |
| 93 | SNN | Smith & Nephew plc | 11.32B | 0.07% | 1,050,008 | 6.30B |
| 94 | DVA | DaVita Inc. | 11.27B | -2.01% | 650,298 | 14.01B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.27B | -1.76% | 256,249 | 1.28B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.17B | -0.53% | 4,196,248 | 5.02B |
| 97 | FMS | Fresenius Medical Care AG | 11.10B | -7.72% | 3,242,640 | 22.19B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.69B | -1.81% | 2,078,983 | 3.41B |
| 99 | COO | The Cooper Companies, Inc. | 10.41B | -2.98% | 4,548,430 | 4.24B |
| 100 | AVTR | Avantor, Inc. | 10.38B | -0.52% | 6,007,520 | 6.56B |
| 101 | RDY | Dr. Reddy's Laboratories Limited | 10.35B | -1.76% | 3,124,827 | 3.50B |
| 102 | IBRX | ImmunityBio, Inc. | 10.33B | 0.62% | 11,780,004 | 165.79M |
| 103 | UHS | Universal Health Services, Inc. | 10.29B | -1.39% | 540,293 | 18.11B |
| 104 | GKOS | Glaukos Corporation | 10.15B | 6.55% | 1,487,662 | 612.84M |
| 105 | MOH | Molina Healthcare, Inc. | 10.15B | -0.18% | 899,136 | 42.47B |
| 106 | OSCR | Oscar Health, Inc. | 10.15B | 1.76% | 5,429,663 | 15.32B |
| 107 | PCVX | Vaxcyte, Inc. | 9.96B | 0.39% | 11,562,312 | - |
| 108 | ALGN | Align Technology, Inc. | 9.94B | -1.12% | 678,977 | 4.14B |
| 109 | TXG | 10x Genomics, Inc. | 9.92B | -5.65% | 9,377,268 | 616.91M |
| 110 | GMED | Globus Medical, Inc. | 9.90B | -3.51% | 2,473,865 | 3.14B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.84B | -0.25% | 251,905 | 2.59B |
| 112 | ENSG | The Ensign Group, Inc. | 9.78B | -1.65% | 458,209 | 5.49B |
| 113 | TWST | Twist Bioscience Corporation | 9.76B | -6.78% | 5,902,878 | 431.80M |
| 114 | KRYS | Krystal Biotech, Inc. | 9.61B | -0.69% | 354,153 | 440.48M |
| 115 | RGEN | Repligen Corporation | 9.44B | -4.37% | 2,630,181 | 785.10M |
| 116 | HSIC | Henry Schein, Inc. | 9.32B | -1.39% | 1,312,085 | 13.60B |
| 117 | PODD | Insulet Corporation | 9.32B | -0.27% | 1,032,906 | 3.05B |
| 118 | QGEN | Qiagen N.V. | 9.26B | -1.88% | 2,578,609 | 2.10B |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 9.12B | 1.61% | 927,270 | 281.99M |
| 120 | BRKR | Bruker Corporation | 9.10B | -1.29% | 2,907,784 | 3.50B |
| 121 | AXSM | Axsome Therapeutics, Inc. | 9.06B | -0.79% | 887,361 | 776.57M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 9.01B | 2.24% | 1,167,424 | 105.00M |
| 123 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.68B | -0.10% | 1,819,296 | 669.50M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.50B | -0.37% | 2,395,560 | 67.67M |
| 125 | HNGE | Hinge Health, Inc. | 7.90B | -0.50% | 2,652,086 | 720.06M |
| 126 | PRAX | Praxis Precision Medicines, Inc. | 7.76B | -0.76% | 444,251 | 7.46M |
| 127 | ABVX | ABIVAX Société Anonyme | 7.67B | -1.37% | 1,387,406 | 5.33M |
| 128 | CAI | Caris Life Sciences, Inc. | 7.66B | -1.31% | 4,881,681 | 989.61M |
| 129 | ATR | AptarGroup, Inc. | 7.66B | 0.15% | 605,911 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.60B | 0.93% | 893,045 | 1.36B |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.56B | 0.92% | 2,719,344 | - |
| 132 | TGTX | TG Therapeutics, Inc. | 7.51B | 1.46% | 1,506,392 | 799.54M |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.34B | 0.36% | 2,943,621 | 874.09M |
| 134 | ALKS | Alkermes plc | 6.95B | -0.49% | 1,816,099 | 1.67B |
| 135 | HIMS | Hims & Hers Health, Inc. | 6.89B | 0.24% | 5,469,607 | 2.58B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 6.84B | -3.20% | 4,663,519 | 3.12B |
| 137 | PACS | PACS Group, Inc. | 6.84B | 0.89% | 673,256 | 5.55B |
| 138 | GRFS | Grifols, S.A. | 6.66B | -0.27% | 260,701 | 8.48B |
| 139 | IMVT | Immunovant, Inc. | 6.62B | -0.22% | 1,131,426 | - |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.54B | 0.23% | 553,778 | 1.56B |
| 141 | CHE | Chemed Corporation | 6.53B | -1.65% | 139,129 | 2.60B |
| 142 | BLTE | Belite Bio, Inc | 6.29B | 0.30% | 97,812 | - |
| 143 | BLCO | Bausch + Lomb Corporation | 6.19B | 0.93% | 349,052 | 5.32B |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.09B | -2.56% | 939,420 | 239.92M |
| 145 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.08B | 1.13% | 381,046 | 840.85M |
| 146 | GRAL | GRAIL, Inc. | 5.94B | -3.19% | 993,220 | 165.26M |
| 147 | IOVA | Iovance Biotherapeutics, Inc. | 5.85B | -0.35% | 14,530,801 | 324.97M |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 5.85B | -1.24% | 309,238 | 290.54M |
| 149 | KOD | Kodiak Sciences Inc. | 5.71B | -1.36% | 1,307,457 | - |
| 150 | CGON | CG Oncology, Inc. | 5.53B | -1.98% | 621,821 | 6.23M |
| 151 | RDNT | RadNet, Inc. | 5.40B | -2.38% | 398,633 | 2.27B |
| 152 | MMED | MiniMed Group, Inc. | 5.38B | -2.70% | 9,619,603 | 3.22B |
| 153 | STVN | Stevanato Group S.p.A. | 5.31B | -2.11% | 285,690 | 1.40B |
| 154 | PTCT | PTC Therapeutics, Inc. | 5.28B | -0.74% | 1,040,493 | 1.01B |
| 155 | TFX | Teleflex Incorporated | 5.27B | -0.21% | 928,300 | 2.25B |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.26B | -0.85% | 809,899 | - |
| 157 | MIRM | Mirum Pharmaceuticals, Inc. | 5.24B | 1.75% | 1,020,896 | 618.07M |
| 158 | COGT | Cogent Biosciences, Inc. | 5.23B | -0.79% | 1,262,895 | - |
| 159 | SRRK | Scholar Rock Holding Corporation | 5.14B | -0.59% | 1,564,410 | - |
| 160 | SHC | Sotera Health Company | 5.11B | -1.92% | 1,609,460 | 1.22B |
| 161 | MMSI | Merit Medical Systems, Inc. | 5.08B | 0.15% | 468,060 | 1.58B |
| 162 | CRSP | CRISPR Therapeutics AG | 5.06B | -3.06% | 1,680,483 | 13.39M |
| 163 | TVTX | Travere Therapeutics, Inc. | 5.04B | -4.54% | 3,424,036 | 591.33M |
| 164 | WAY | Waystar Holding Corp. | 4.94B | -2.39% | 1,773,025 | 1.21B |
| 165 | ERAS | Erasca, Inc. | 4.94B | -1.26% | 3,853,882 | - |
| 166 | DOCS | Doximity, Inc. | 4.94B | -0.36% | 2,389,056 | 655.57M |
| 167 | DNTH | Dianthus Therapeutics, Inc. | 4.75B | -0.61% | 562,472 | 1.90M |
| 168 | DFTX | Definium Therapeutics, Inc. | 4.71B | -1.49% | 1,967,116 | - |
| 169 | OPCH | Option Care Health, Inc. | 4.64B | 0.03% | 19,352,340 | 5.69B |
| 170 | CON | Concentra Group Holdings Parent, Inc. | 4.64B | - | 1,293,099 | 2.29B |
| 171 | MANE | Veradermics, Incorporated | 4.64B | 1.83% | 655,089 | - |
| 172 | LFST | LifeStance Health Group, Inc. | 4.63B | -0.08% | 3,652,960 | 1.58B |
| 173 | HAE | Haemonetics Corporation | 4.63B | -1.75% | 625,576 | 1.35B |
| 174 | BLLN | BillionToOne, Inc. | 4.52B | -4.19% | 679,892 | 397.41M |
| 175 | ITGR | Integer Holdings Corporation | 4.30B | 0.09% | 356,692 | 1.84B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.30B | -1.12% | 1,446,113 | - |
| 177 | HTFL | HeartFlow, Inc. | 4.29B | -2.62% | 1,442,797 | 212.07M |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.26B | 0.64% | 1,769,649 | 1.33B |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.19B | -2.30% | 2,120,225 | 308.08M |
| 180 | LIVN | LivaNova PLC | 4.18B | 1.33% | 692,098 | 1.47B |
| 181 | ABCL | AbCellera Biologics Inc. | 4.16B | -2.43% | 5,004,912 | 66.17M |
| 182 | RLAY | Relay Therapeutics, Inc. | 3.93B | -4.22% | 3,433,042 | 10.35M |
| 183 | ICUI | ICU Medical, Inc. | 3.90B | -2.32% | 214,616 | 2.16B |
| 184 | TLX | Telix Pharmaceuticals Limited | 3.75B | 3.15% | 817,437 | 890.79M |
| 185 | LEGN | Legend Biotech Corporation | 3.70B | 2.14% | 1,569,303 | 1.27B |
| 186 | NVST | Envista Holdings Corporation | 3.70B | -0.99% | 1,825,473 | 2.86B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.68B | -0.32% | 3,392,793 | 53.81M |
| 188 | OGN | Organon & Co. | 3.62B | 0.36% | 2,208,085 | 6.13B |
| 189 | PBLS | Parabilis Medicines, Inc. | 3.56B | -0.14% | 994,003 | 148.00K |
| 190 | XENE | Xenon Pharmaceuticals Inc. | 3.53B | -0.44% | 1,967,330 | 7.50M |
| 191 | RGC | Regencell Bioscience Holdings Limited | 3.52B | -3.27% | 109,910 | - |
| 192 | PLSE | Pulse Biosciences, Inc. | 3.50B | -1.33% | 409,472 | 1.19M |
| 193 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | -1.01% | 552,057 | 234.13M |
| 194 | VCYT | Veracyte, Inc. | 3.47B | -3.34% | 1,213,626 | 561.90M |
| 195 | NHC | National HealthCare Corporation | 3.46B | -3.10% | 100,865 | 1.56B |
| 196 | IRTC | iRhythm Holdings, Inc. | 3.46B | -2.06% | 450,304 | 825.34M |
| 197 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.44B | -2.18% | 2,056,710 | -665.00K |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.39B | -0.46% | 1,784,748 | 1.14B |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.33B | 0.56% | 5,410,049 | - |
| 200 | CDNA | CareDx, Inc. | 3.26B | -1.18% | 1,700,938 | 458.09M |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.23B | -0.67% | 542,285 | 606.33M |
| 202 | CELC | Celcuity Inc. | 3.22B | -7.68% | 3,156,462 | - |
| 203 | WRBY | Warby Parker Inc. | 3.13B | -3.51% | 1,725,657 | 911.61M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.12B | 0.99% | 1,601,275 | 117.00M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.06B | -0.62% | 1,314,474 | 3.60M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | 1.05% | 1,725,984 | 463.98M |
| 207 | ELVN | Enliven Therapeutics, Inc. | 3.03B | -2.43% | 1,461,363 | - |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.98B | 3.70% | 3,489,863 | - |
| 209 | ZLAB | Zai Lab Limited | 2.84B | -1.06% | 290,197 | 449.61M |
| 210 | TMDX | TransMedics Group, Inc. | 2.81B | 0.98% | 962,659 | 668.47M |
| 211 | ACHC | Acadia Healthcare Company, Inc. | 2.72B | 0.65% | 1,652,181 | 3.37B |
| 212 | ATRC | AtriCure, Inc. | 2.71B | -0.69% | 753,530 | 569.62M |
| 213 | PGEN | Precigen, Inc. | 2.70B | -0.13% | 4,152,552 | 85.72M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.69B | 0.74% | 4,606,083 | 2.60B |
| 215 | NAMS | NewAmsterdam Pharma Company N.V. | 2.65B | -0.63% | 1,378,849 | 7.12M |
| 216 | MBX | MBX Biosciences, Inc. | 2.63B | -4.18% | 357,159 | - |
| 217 | PRVA | Privia Health Group, Inc. | 2.59B | 0.10% | 1,608,518 | 2.36B |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | -1.26% | 388,311 | 1.46B |
| 219 | BKD | Brookdale Senior Living Inc. | 2.57B | -1.19% | 6,604,242 | 2.93B |
| 220 | HCM | HUTCHMED (China) Limited | 2.55B | -2.19% | 58,035 | 549.12M |
| 221 | NEOG | Neogen Corporation | 2.55B | -2.34% | 12,969,336 | 884.00M |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.50B | 0.51% | 571,037 | 830.44M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.48B | -1.82% | 2,342,844 | 156.04M |
| 224 | CLOV | Clover Health Investments, Corp. | 2.42B | -0.87% | 7,423,473 | 2.48B |
| 225 | CLDX | Celldex Therapeutics, Inc. | 2.39B | -1.87% | 1,746,939 | 158.00K |
| 226 | LQDA | Liquidia Corporation | 2.39B | 2.97% | 6,987,843 | 450.91M |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.36B | 0.58% | 1,631,787 | 36.77M |
| 228 | IRON | Disc Medicine, Inc. | 2.35B | -0.76% | 562,929 | - |
| 229 | BHC | Bausch Health Companies Inc. | 2.30B | 2.16% | 2,005,386 | 10.85B |
| 230 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | -0.05% | 547,001 | 959.90M |
| 231 | RXRX | Recursion Pharmaceuticals, Inc. | 2.29B | -7.78% | 40,730,497 | 54.86M |
| 232 | SLS | SELLAS Life Sciences Group, Inc. | 2.28B | -0.26% | 3,142,287 | - |
| 233 | ADMA | ADMA Biologics, Inc. | 2.27B | -0.39% | 3,049,652 | 512.28M |
| 234 | UFPT | UFP Technologies, Inc. | 2.27B | -3.30% | 114,114 | 631.64M |
| 235 | PBH | Prestige Consumer Healthcare Inc. | 2.25B | 2.43% | 460,853 | 1.10B |
| 236 | PHVS | Pharvaris N.V. | 2.22B | 1.80% | 341,843 | - |
| 237 | BFLY | Butterfly Network, Inc. | 2.20B | -4.94% | 7,543,036 | 112.14M |
| 238 | VERA | Vera Therapeutics, Inc. | 2.18B | 2.82% | 3,290,715 | - |
| 239 | IMNM | Immunome, Inc. | 2.17B | -1.11% | 1,161,063 | 4.02M |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.15B | 5.66% | 5,122,733 | 940.61M |
| 241 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 2.04% | 682,530 | 311.51M |
| 242 | AXGN | Axogen, Inc. | 2.11B | -0.74% | 1,602,453 | 251.17M |
| 243 | PGNY | Progyny, Inc. | 2.11B | 6.33% | 2,263,111 | 1.31B |
| 244 | ALVO | Alvotech | 2.09B | -4.72% | 864,565 | 494.61M |
| 245 | VCEL | Vericel Corporation | 2.09B | 1.72% | 647,001 | 306.30M |
| 246 | TRLV | Trulieve Cannabis Corp. | 2.08B | 1.22% | 2,012,105 | 1.14B |
| 247 | ADUS | Addus HomeCare Corporation | 2.07B | 0.10% | 229,453 | 1.48B |
| 248 | VRDN | Viridian Therapeutics, Inc. | 2.07B | 0.33% | 1,691,094 | 71.13M |
| 249 | NEO | NeoGenomics, Inc. | 2.05B | -3.27% | 3,192,188 | 766.30M |
| 250 | MD | Pediatrix Medical Group, Inc. | 2.05B | -0.65% | 655,825 | 1.95B |
| 251 | WGS | GeneDx Holdings Corp. | 2.04B | -4.18% | 659,342 | 454.43M |
| 252 | SDGR | Schrödinger, Inc. | 2.04B | -5.57% | 4,560,900 | 259.04M |
| 253 | PRGO | Perrigo Company plc | 2.02B | 3.93% | 1,906,622 | 4.14B |
| 254 | URGN | UroGen Pharma Ltd. | 1.99B | -1.76% | 486,475 | 188.73M |
| 255 | FTRE | Fortrea Holdings Inc. | 1.96B | -1.06% | 2,245,344 | 2.68B |
| 256 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | 0.64% | 989,115 | - |
| 257 | INSP | Inspire Medical Systems, Inc. | 1.95B | -1.10% | 1,484,438 | 898.74M |
| 258 | VIR | Vir Biotechnology, Inc. | 1.95B | -0.69% | 3,561,899 | 303.23M |
| 259 | ADRX | ADARx Pharmaceuticals, Inc. | 1.94B | -6.73% | 705,704 | 6.13M |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | -5.35% | 4,272,662 | 208.78M |
| 261 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 2.32% | 362,252 | 1.13B |
| 262 | ALMR | Alamar Biosciences, Inc. | 1.93B | -13.92% | 1,148,153 | 100.42M |
| 263 | ESTA | Establishment Labs Holdings Inc. | 1.90B | -2.21% | 438,397 | 245.82M |
| 264 | GPCR | Structure Therapeutics Inc. | 1.90B | -2.88% | 1,049,043 | - |
| 265 | ASTH | Astrana Health, Inc. | 1.90B | 0.38% | 664,507 | 3.84B |
| 266 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | 0.22% | 1,673,116 | 98.34M |
| 267 | ZYME | Zymeworks Inc. | 1.88B | 3.43% | 1,620,663 | 37.13M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.88B | 2.02% | 151,992 | - |
| 269 | TRVI | Trevi Therapeutics, Inc. | 1.87B | -0.30% | 5,366,869 | - |
| 270 | NVAX | Novavax, Inc. | 1.85B | -0.88% | 8,381,208 | 413.80M |
| 271 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 1.10% | 2,872,996 | 1.97B |
| 272 | XERS | Xeris Biopharma Holdings, Inc. | 1.84B | 0.40% | 2,220,939 | 335.41M |
| 273 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 4.60% | 509,230 | 1.00M |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.81B | 0.33% | 218,312 | 262.43M |
| 275 | XNCR | Xencor, Inc. | 1.80B | -0.41% | 1,696,620 | 104.97M |
| 276 | BHVN | Biohaven Ltd. | 1.79B | -1.66% | 2,147,173 | - |
| 277 | SGRY | Surgery Partners, Inc. | 1.78B | 2.24% | 1,685,898 | 3.37B |
| 278 | ALHC | Alignment Healthcare, Inc. | 1.77B | 2.15% | 6,563,824 | 4.58B |
| 279 | MESO | Mesoblast Limited | 1.75B | 2.42% | 242,130 | 120.25M |
| 280 | GENB | Generate Biomedicines, Inc. | 1.74B | -1.67% | 926,428 | 26.48M |
| 281 | FRNM | Freenome, Inc. | 1.72B | -2.02% | 648,251 | 35.41M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.72B | -2.45% | 690,132 | 481.07M |
| 283 | PSNL | Personalis, Inc. | 1.71B | -0.19% | 3,818,004 | 69.67M |
| 284 | NVCR | NovoCure Limited | 1.71B | -2.07% | 3,513,339 | 699.19M |
| 285 | NUVB | Nuvation Bio Inc. | 1.71B | -0.41% | 5,449,991 | 169.90M |
| 286 | XRAY | DENTSPLY SIRONA Inc. | 1.70B | 0.23% | 4,221,269 | 3.64B |
| 287 | SEPN | Septerna, Inc. | 1.68B | 0.93% | 1,028,375 | 98.88M |
| 288 | NTLA | Intellia Therapeutics, Inc. | 1.64B | -5.34% | 8,298,220 | 59.51M |
| 289 | CMPS | COMPASS Pathways plc | 1.62B | 1.12% | 1,586,412 | - |
| 290 | OMCL | Omnicell, Inc. | 1.61B | -0.71% | 570,639 | 1.25B |
| 291 | QURE | uniQure N.V. | 1.61B | 0.35% | 1,777,490 | 18.67M |
| 292 | OCUL | Ocular Therapeutix, Inc. | 1.59B | -1.50% | 2,932,671 | 52.06M |
| 293 | ATEC | Alphatec Holdings, Inc. | 1.58B | -2.75% | 2,439,046 | 815.05M |
| 294 | ABSI | Absci Corporation | 1.58B | -10.22% | 5,850,923 | 1.56M |
| 295 | KMTS | Kestra Medical Technologies, Ltd. | 1.58B | -2.25% | 399,456 | 106.73M |
| 296 | AZTA | Azenta, Inc. | 1.57B | -8.79% | 1,690,989 | 613.81M |
| 297 | ETON | Eton Pharmaceuticals, Inc. | 1.57B | 0.20% | 774,679 | 105.60M |
| 298 | STOK | Stoke Therapeutics, Inc. | 1.57B | -0.33% | 637,097 | 27.59M |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | 0.57% | 438,193 | 978.38M |
| 300 | ARDT | Ardent Health, Inc. | 1.53B | 1.87% | 684,129 | 6.41B |
| 301 | PAHC | Phibro Animal Health Corporation | 1.53B | 3.03% | 199,528 | 1.52B |
| 302 | INVA | Innoviva, Inc. | 1.52B | 1.10% | 636,391 | 440.00M |
| 303 | SNDX | Syndax Pharmaceuticals, Inc. | 1.52B | -1.96% | 1,589,729 | 252.25M |
| 304 | BRVE | Braveheart Bio, Inc. | 1.52B | -6.11% | 336,949 | - |
| 305 | IMCR | Immunocore Holdings plc | 1.51B | -0.47% | 343,752 | 430.78M |
| 306 | RAPP | Rapport Therapeutics, Inc. | 1.48B | -0.93% | 314,989 | 20.00M |
| 307 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | 2.97% | 4,162,727 | 717.00M |
| 308 | NUTX | Nutex Health Inc. | 1.46B | -2.46% | 237,112 | 846.72M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.46B | -0.68% | 823,901 | 20.00M |
| 310 | GHRS | GH Research PLC | 1.45B | -2.14% | 304,766 | - |
| 311 | TSHA | Taysha Gene Therapies, Inc. | 1.44B | 0.91% | 3,912,411 | 5.49M |
| 312 | KRSA | Korsana Biosciences, Inc. | 1.44B | -0.38% | 37,078 | - |
| 313 | AGL | agilon health, inc. | 1.44B | 2.76% | 355,694 | 5.92B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.43B | -1.61% | 1,129,174 | 1.86B |
| 315 | AMN | AMN Healthcare Services, Inc. | 1.41B | -0.54% | 570,941 | 3.43B |
| 316 | TYRA | Tyra Biosciences, Inc. | 1.40B | 0.74% | 477,744 | - |
| 317 | PNTG | The Pennant Group, Inc. | 1.38B | -0.85% | 979,961 | 1.10B |
| 318 | NKTR | Nektar Therapeutics | 1.37B | 0.88% | 1,510,550 | 54.59M |
| 319 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -0.05% | 223,780 | 1.30M |
| 320 | CERT | Certara, Inc. | 1.37B | -3.34% | 3,426,634 | 421.75M |
| 321 | KLRA | Kailera Therapeutics, Inc. | 1.37B | -2.77% | 1,091,732 | - |
| 322 | ANAB | AnaptysBio, Inc. | 1.36B | -4.68% | 766,532 | 106.09M |
| 323 | OMER | Omeros Corporation | 1.36B | 1.30% | 622,924 | 38.42M |
| 324 | COAG | Hemab Therapeutics Holdings, Inc. | 1.34B | 1.16% | 377,185 | - |
| 325 | CNMD | CONMED Corporation | 1.32B | -0.56% | 521,294 | 1.37B |
| 326 | DRTS | Alpha Tau Medical Ltd. | 1.32B | -1.59% | 466,366 | - |
| 327 | AAPG | Ascentage Pharma Group International | 1.31B | -7.15% | 7,242 | 94.61M |
| 328 | KARD | Kardigan, Inc. | 1.29B | 2.52% | 1,025,707 | - |
| 329 | OMDA | Omada Health, Inc. | 1.28B | 0.77% | 1,257,833 | 309.76M |
| 330 | NBTX | Nanobiotix S.A. | 1.27B | -2.42% | 142,649 | 13.15M |
| 331 | DMRA | Damora Therapeutics, Inc. | 1.25B | 3.53% | 488,753 | - |
| 332 | INNV | InnovAge Holding Corp. | 1.25B | 1.44% | 342,157 | 989.71M |
| 333 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | 0.25% | 790,783 | - |
| 334 | REPL | Replimune Group, Inc. | 1.24B | -0.38% | 1,647,279 | - |
| 335 | SVRA | Savara Inc. | 1.24B | 4.95% | 2,415,258 | - |
| 336 | USPH | U.S. Physical Therapy, Inc. | 1.24B | -0.80% | 233,953 | 804.27M |
| 337 | CRON | Cronos Group Inc. | 1.19B | -1.37% | 456,035 | 179.09M |
| 338 | HROW | Harrow, Inc. | 1.15B | 0.89% | 708,529 | 275.59M |
| 339 | AVLN | Avalyn Pharma Inc. | 1.13B | 0.39% | 202,933 | - |
| 340 | STAA | STAAR Surgical Company | 1.12B | 0.95% | 779,784 | 339.59M |
| 341 | VOR | Vor Biopharma Inc. | 1.11B | 2.57% | 563,088 | - |
| 342 | MNKD | MannKind Corporation | 1.11B | -7.01% | 6,010,063 | 393.63M |
| 343 | GDRX | GoodRx Holdings, Inc. | 1.11B | -0.61% | 548,461 | 785.23M |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.10B | -1.98% | 2,273,377 | 1.04B |
| 345 | LBRX | LB Pharmaceuticals Inc | 1.10B | -0.29% | 385,034 | - |
| 346 | JANX | Janux Therapeutics, Inc. | 1.10B | 6.73% | 1,210,337 | 24.00M |
| 347 | TRAX | First Tracks Biotherapeutics, Inc. | 1.09B | -2.55% | 355,525 | - |
| 348 | IRMD | IRADIMED CORPORATION | 1.09B | 0.77% | 197,892 | 86.34M |
| 349 | BCAX | Bicara Therapeutics Inc. | 1.09B | -0.85% | 915,596 | - |
| 350 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.09B | -1.43% | 776,285 | 730.02M |
| 351 | BVS | Bioventus Inc. | 1.07B | -2.52% | 365,218 | 581.85M |
| 352 | AORT | Artivion, Inc. | 1.05B | -1.05% | 351,961 | 471.47M |
| 353 | MGTX | MeiraGTx Holdings plc | 1.04B | 2.08% | 2,309,962 | 397.50M |
| 354 | OPK | OPKO Health, Inc. | 1.04B | -4.79% | 2,224,403 | 587.90M |
| 355 | AHG | Akso Health Group | 1.04B | 3.42% | 16,762 | 13.83M |
| 356 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | -4.55% | 241,512 | - |
| 357 | PRCT | PROCEPT BioRobotics Corporation | 1.03B | 2.28% | 1,149,519 | 337.34M |
| 358 | IMTX | Immatics N.V. | 1.02B | -0.67% | 926,189 | 47.65M |
| 359 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | -1.12% | 164,015 | 1.04B |
| 360 | ENOV | Enovis Corporation | 1.02B | -3.24% | 1,289,809 | 2.30B |
| 361 | IART | Integra LifeSciences Holdings Corporation | 1.01B | -2.40% | 1,408,453 | 1.65B |
| 362 | TDOC | Teladoc Health, Inc. | 1.01B | -3.64% | 3,624,109 | 2.49B |
| 363 | CSTL | Castle Biosciences, Inc. | 1.01B | -1.08% | 351,527 | 357.28M |
| 364 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | -3.82% | 808,186 | - |
| 365 | PCRX | Pacira BioSciences, Inc. | 1.00B | 1.78% | 802,729 | 746.16M |
| 366 | AKTS | Aktis Oncology, Inc. | 1.00B | 0.78% | 294,105 | 10.06M |
| 367 | HSTM | HealthStream, Inc. | 982.13M | 2.52% | 228,387 | 321.12M |
| 368 | SPTX | Seaport Therapeutics, Inc. | 959.80M | 3.22% | 249,081 | - |
| 369 | BBNX | Beta Bionics, Inc. | 951.76M | -2.95% | 1,531,155 | 119.01M |
| 370 | KURA | Kura Oncology, Inc. | 949.21M | 1.33% | 1,098,974 | 77.23M |
| 371 | ANRO | Alto Neuroscience, Inc. | 922.97M | -0.72% | 348,028 | - |
| 372 | MLTX | MoonLake Immunotherapeutics | 916.60M | -1.64% | 1,396,506 | - |
| 373 | ANL | Adlai Nortye Group Ltd. | 904.79M | -2.84% | 95,062 | 18.06M |
| 374 | CBLL | CeriBell, Inc. | 901.12M | -3.53% | 305,400 | 101.96M |
| 375 | RIGL | Rigel Pharmaceuticals, Inc. | 896.45M | 4.08% | 232,585 | 276.79M |
| 376 | ALMS | Alumis Inc. | 876.28M | -2.31% | 2,170,153 | 7.40M |
| 377 | JBIO | Jade Biosciences, Inc. | 875.74M | 2.68% | 951,275 | - |
| 378 | CRVS | Corvus Pharmaceuticals, Inc. | 875.70M | -1.42% | 1,157,404 | - |
| 379 | GLUE | Monte Rosa Therapeutics, Inc. | 867.64M | 3.04% | 2,081,663 | 28.73M |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 866.37M | -0.28% | 264,070 | 99.00K |
| 381 | SLBT | SL Science Holding Limited | 861.10M | -0.66% | 68,409 | 3.27M |
| 382 | SIBN | SI-BONE, Inc. | 856.03M | -2.30% | 547,633 | 213.60M |
| 383 | ABUS | Arbutus Biopharma Corporation | 848.77M | -4.24% | 4,790,516 | 181.72M |
| 384 | PACB | Pacific Biosciences of California, Inc. | 845.46M | 0.74% | 20,366,654 | 159.27M |
| 385 | QDEL | QuidelOrtho Corporation | 844.16M | -2.07% | 2,456,574 | 2.67B |
| 386 | AVBP | ArriVent BioPharma, Inc. | 832.81M | 11.93% | 4,334,786 | - |
| 387 | OBX | Obsidian Therapeutics, Inc. | 815.40M | -0.15% | 359,042 | - |
| 388 | SANA | Sana Biotechnology, Inc. | 814.26M | -1.09% | 4,315,445 | - |
| 389 | ARDX | Ardelyx, Inc. | 812.35M | -1.51% | 5,389,484 | 450.89M |
| 390 | INMD | InMode Ltd. | 805.31M | 0.14% | 511,976 | 374.63M |
| 391 | SGP | SpyGlass Pharma, Inc. | 799.41M | -3.55% | 69,483 | - |
| 392 | IVA | Inventiva S.A. | 788.04M | -2.75% | 2,403,604 | 2.81M |
| 393 | IMMX | Immix Biopharma, Inc. | 786.75M | -1.56% | 1,382,075 | - |
| 394 | AHCO | AdaptHealth Corp. | 784.45M | 1.91% | 2,884,618 | 3.36B |
| 395 | GMRS | GMR Solutions Inc. | 784.21M | -1.08% | 724,080 | 5.88B |
| 396 | LXRX | Lexicon Pharmaceuticals, Inc. | 783.12M | 0.57% | 1,100,197 | 41.47M |
| 397 | VREX | Varex Imaging Corporation | 777.21M | -0.22% | 601,121 | 865.00M |
| 398 | DNA | Ginkgo Bioworks Holdings, Inc. | 772.39M | -7.57% | 6,457,543 | 132.42M |
| 399 | GERN | Geron Corporation | 770.97M | -0.83% | 5,140,511 | 204.56M |
| 400 | HELP | Helus Pharma Inc. | 767.86M | -2.32% | 832,076 | - |
| 401 | ANNX | Annexon, Inc. | 760.21M | -0.50% | 2,450,040 | - |
| 402 | CADL | Candel Therapeutics, Inc. | 751.41M | -0.51% | 714,955 | - |
| 403 | APMD | Apnimed, Inc. | 751.02M | -3.27% | 465,623 | 115.12M |
| 404 | ATTO | Attovia Therapeutics, Inc. | 749.59M | -6.17% | 515,713 | 1.80M |
| 405 | VSTM | Verastem, Inc. | 748.51M | 6.65% | 3,928,559 | 87.53M |
| 406 | GYRE | Gyre Therapeutics, Inc. | 746.48M | -0.56% | 99,188 | 109.82M |
| 407 | ACHV | Achieve Life Sciences, Inc. | 745.01M | 2.99% | 1,035,937 | - |
| 408 | SLDB | Solid Biosciences Inc. | 734.49M | -1.01% | 744,708 | - |
| 409 | DSGN | Design Therapeutics, Inc. | 731.58M | -2.34% | 344,454 | - |
| 410 | AVTX | Avalo Therapeutics, Inc. | 728.30M | -0.07% | 719,026 | 59.00K |
| 411 | COLL | Collegium Pharmaceutical, Inc. | 713.94M | 0.23% | 783,474 | 808.21M |
| 412 | WVE | Wave Life Sciences, Inc. | 697.55M | 0.57% | 3,052,733 | 65.37M |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 695.52M | 0.24% | 603,568 | 92.01M |
| 414 | OLMA | Olema Pharmaceuticals, Inc. | 694.73M | 0.25% | 819,455 | - |
| 415 | CTKB | Cytek Biosciences, Inc. | 694.11M | -0.74% | 1,782,599 | 206.71M |
| 416 | PRME | Prime Medicine, Inc. | 693.83M | 11.43% | 11,202,329 | 4.07M |
| 417 | PHAR | Pharming Group N.V. | 681.88M | -0.31% | 3,834 | 366.48M |
| 418 | MDXG | MiMedx Group, Inc. | 671.96M | -0.22% | 821,148 | 355.17M |
| 419 | AURA | Aura Biosciences, Inc. | 669.93M | 4.70% | 723,720 | - |
| 420 | AVR | Anteris Technologies Global Corp. | 664.91M | -3.26% | 2,454,137 | 2.24M |
| 421 | OABI | OmniAb, Inc. | 662.98M | 4.83% | 1,498,537 | 38.46M |
| 422 | NVCT | Nuvectis Pharma, Inc. | 661.08M | 1.30% | 121,091 | - |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 657.97M | 3.26% | 936,491 | 136.07M |
| 424 | STLN | Starling Oncology, Inc. | 655.32M | -2.28% | 949,110 | 587.24M |
| 425 | PHR | Phreesia, Inc. | 651.74M | 2.44% | 595,891 | 507.79M |
| 426 | FTH | Faeth Therapeutics, Inc. | 643.94M | -7.33% | 322,640 | - |
| 427 | SGMT | Sagimet Biosciences Inc. | 629.67M | 1.37% | 631,650 | - |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 619.65M | 3.31% | 2,051,192 | 389.32M |
| 429 | CLYM | Climb Bio, Inc. | 615.14M | 0.28% | 755,808 | - |
| 430 | SOPH | SOPHiA GENETICS SA | 608.66M | -3.12% | 432,833 | 86.17M |
| 431 | SLN | Silence Therapeutics plc | 591.26M | -0.10% | 1,319,570 | 615.00K |
| 432 | WEAV | Weave Communications, Inc. | 589.59M | -0.14% | 674,228 | 257.79M |
| 433 | DBVT | DBV Technologies S.A. | 588.19M | -2.10% | 535,276 | 5.04M |
| 434 | KIDS | OrthoPediatrics Corp. | 586.95M | -1.01% | 180,084 | 252.72M |
| 435 | ANGO | AngioDynamics, Inc. | 586.51M | -1.60% | 1,012,599 | 325.38M |
| 436 | EVO | Evotec SE | 583.68M | -1.23% | 93,136 | 819.47M |
| 437 | AQST | Aquestive Therapeutics, Inc. | 579.86M | 0.22% | 1,357,060 | 54.09M |
| 438 | CBIO | Crescent Biopharma, Inc. | 577.39M | -0.59% | 1,049,276 | 11.88M |
| 439 | ETRA | Electra Therapeutics, Inc. | 574.95M | -6.72% | 407,261 | - |
| 440 | STTK | Shattuck Labs, Inc. | 567.55M | -3.50% | 1,109,329 | 1.00M |
| 441 | CRMD | CorMedix Inc. | 567.43M | - | 833,077 | 462.25M |
| 442 | FLGT | Fulgent Genetics, Inc. | 565.99M | -0.05% | 298,274 | 323.93M |
| 443 | MNPR | Monopar Therapeutics Inc. | 562.35M | 5.29% | 107,139 | - |
| 444 | CTMX | CytomX Therapeutics, Inc. | 555.64M | -0.39% | 2,341,381 | 18.30M |
| 445 | VALN | Valneva SE | 553.34M | 0.17% | 26,266 | 163.30M |
| 446 | SSII | SS Innovations International, Inc. | 549.06M | -0.72% | 20,835 | 52.40M |
| 447 | PHAT | Phathom Pharmaceuticals, Inc. | 540.92M | 0.44% | 1,630,667 | 239.66M |
| 448 | DCTH | Delcath Systems, Inc. | 533.67M | -0.19% | 263,076 | 95.42M |
| 449 | BLSM | BlossomHill Therapeutics, Inc. | 527.95M | -3.93% | 253,806 | - |
| 450 | OCS | Oculis Holding AG | 524.72M | -2.52% | 173,694 | 1.45M |
| 451 | MPLT | MapLight Therapeutics, Inc. | 520.19M | -3.41% | 275,186 | - |
| 452 | NGNE | Neurogene Inc. | 517.69M | 1.65% | 114,069 | 925.00K |
| 453 | ALT | Altimmune, Inc. | 517.42M | -0.37% | 3,168,244 | 31.00K |
| 454 | EOLS | Evolus, Inc. | 511.23M | 4.88% | 595,192 | 316.49M |
| 455 | EPRX | Eupraxia Pharmaceuticals Inc. | 509.76M | 0.52% | 853,311 | - |
| 456 | TLRY | Tilray Brands, Inc. | 508.92M | -1.72% | 3,368,215 | 963.10M |
| 457 | DRUG | Bright Minds Biosciences Inc. | 508.68M | 7.77% | 688,820 | - |
| 458 | PBYI | Puma Biotechnology, Inc. | 506.39M | 3.26% | 375,313 | 231.24M |
| 459 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 460 | RGNX | REGENXBIO Inc. | 501.37M | 1.95% | 1,004,864 | 174.48M |
| 461 | ACRS | Aclaris Therapeutics, Inc. | 500.48M | -8.11% | 9,003,171 | 8.22M |
| 462 | TCMD | Tactile Systems Technology, Inc. | 498.80M | -0.77% | 215,984 | 350.31M |
| 463 | ALLO | Allogene Therapeutics, Inc. | 494.05M | -2.05% | 3,899,723 | 4.64M |
| 464 | ARVN | Arvinas, Inc. | 487.13M | 1.92% | 601,836 | 316.70M |
| 465 | MASS | 908 Devices Inc. | 486.91M | -4.46% | 517,208 | 60.84M |
| 466 | SENS | Senseonics Holdings, Inc. | 484.33M | -8.03% | 637,679 | 48.55M |
| 467 | GLAS | Glass House Brands Inc. | 483.46M | -0.58% | 793,382 | 176.98M |
| 468 | AUTL | Autolus Therapeutics plc | 481.75M | 1.12% | 1,551,347 | 117.39M |
| 469 | CTNM | Contineum Therapeutics, Inc. | 478.92M | 0.63% | 707,729 | - |
| 470 | PROK | ProKidney Corp. | 474.65M | -1.88% | 832,187 | 818.00K |
| 471 | CAPR | Capricor Therapeutics, Inc. | 470.93M | 4.52% | 2,885,464 | 11.13M |
| 472 | EVH | Evolent Health, Inc. | 468.07M | 7.81% | 2,802,978 | 2.10B |
| 473 | TKNO | Alpha Teknova, Inc. | 467.62M | -0.46% | 267,692 | 43.70M |
| 474 | ASMB | Assembly Biosciences, Inc. | 467.28M | 3.47% | 190,787 | 74.85M |
| 475 | SGHT | Sight Sciences, Inc. | 466.60M | -1.05% | 233,484 | 83.38M |
| 476 | BWAY | BrainsWay Ltd. | 466.55M | -2.27% | 132,355 | 60.70M |
| 477 | CERS | Cerus Corporation | 461.49M | -2.14% | 888,398 | 221.55M |
| 478 | OVID | Ovid Therapeutics Inc. | 460.90M | -0.42% | 1,003,730 | 1.58M |
| 479 | RZLT | Rezolute, Inc. | 459.45M | 1.39% | 1,689,852 | - |
| 480 | KMDA | Kamada Ltd. | 454.57M | -2.71% | 72,837 | 191.85M |
| 481 | NRC | NRC Health | 446.59M | 0.55% | 68,576 | 140.00M |
| 482 | TECX | Tectonic Therapeutic, Inc. | 443.97M | 1.34% | 300,791 | - |
| 483 | NPCE | NeuroPace, Inc. | 437.98M | 0.71% | 127,177 | 106.99M |
| 484 | PRTA | Prothena Corporation plc | 435.34M | 5.74% | 690,413 | 54.53M |
| 485 | ENTX | Entera Bio Ltd. | 434.59M | -0.79% | 679,477 | 42.00K |
| 486 | SPRY | ARS Pharmaceuticals, Inc. | 433.59M | 1.51% | 1,297,977 | 116.93M |
| 487 | AGMB | AgomAb Therapeutics NV | 433.38M | -0.45% | 104,931 | - |
| 488 | DMAC | DiaMedica Therapeutics Inc. | 430.87M | -1.72% | 221,231 | - |
| 489 | CTEV | Claritev Corporation | 424.19M | 3.90% | 216,220 | 994.67M |
| 490 | EDIT | Editas Medicine, Inc. | 422.35M | 0.73% | 2,264,998 | 47.01M |
| 491 | YDES | YD Bio Limited | 416.49M | -4.39% | 135,928 | 1.24M |
| 492 | SRTA | Strata Critical Medical, Inc. | 414.02M | -1.47% | 703,941 | 255.98M |
| 493 | MYGN | Myriad Genetics, Inc. | 409.38M | - | 1,600,180 | 806.60M |
| 494 | EIKN | Eikon Therapeutics, Inc. | 408.40M | 0.40% | 920,165 | - |
| 495 | RCEL | AVITA Medical, Inc. | 403.60M | 0.46% | 263,055 | 75.63M |
| 496 | AVIR | Atea Pharmaceuticals, Inc. | 401.83M | -1.18% | 264,766 | - |
| 497 | ZURA | Zura Bio Limited | 399.61M | 5.30% | 2,084,809 | - |
| 498 | PRLD | Prelude Therapeutics Incorporated | 394.47M | 0.52% | 454,698 | 22.42M |
| 499 | CARL | Carlsmed, Inc. | 392.61M | -1.78% | 52,094 | 63.30M |
| 500 | SI | Shoulder Innovations, Inc. | 389.52M | -2.25% | 81,760 | 60.06M |